• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.

作者信息

Dentali F, Ageno W, Bozzato S, Malato A, Gianni M, Squizzato A, Prisco D

出版信息

J Thromb Haemost. 2012 Apr;10(4):732-7. doi: 10.1111/j.1538-7836.2012.04656.x.

DOI:10.1111/j.1538-7836.2012.04656.x
PMID:22329698
Abstract
摘要

相似文献

1
Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.凝血因子V莱顿突变或凝血酶原G20210A突变在有症状的肺栓塞和深静脉血栓形成患者中的作用：文献荟萃分析
J Thromb Haemost. 2012 Apr;10(4):732-7. doi: 10.1111/j.1538-7836.2012.04656.x.
2
Comparison of the risk of pulmonary embolism and deep vein thrombosis in the presence of factor V Leiden or prothrombin G20210A.存在因子V莱顿突变或凝血酶原G20210A时肺栓塞和深静脉血栓形成风险的比较。
Thromb Haemost. 2000 Feb;83(2):352-4.
3
Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.伴有因子V莱顿突变或凝血酶原G20210A突变的患者以及无血栓形成倾向患者的静脉血栓栓塞类型和部位
J Thromb Haemost. 2007 Jan;5(1):98-101. doi: 10.1111/j.1538-7836.2006.02291.x. Epub 2006 Oct 25.
4
Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?杂合子因子V莱顿突变和凝血酶原G20210A突变对静脉血栓栓塞的类型和部位是否有不同影响？
Int Angiol. 2014 Aug;33(4):404-5.
5
The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors.2007年约翰·查恩利奖。全髋关节置换术后深静脉血栓形成和肺栓塞低发生率的相关因素：遗传和血栓形成前因素分析
Clin Orthop Relat Res. 2007 Dec;465:33-9. doi: 10.1097/BLO.0b013e318156bfac.
6
Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.凝血因子V莱顿突变（G1691A）和凝血酶原基因G20210A突变作为全髋关节或全膝关节置换术后静脉血栓栓塞的潜在危险因素。
Thromb Haemost. 2002 Apr;87(4):580-5.
7
Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.中国深静脉血栓形成和肺栓塞患者中凝血因子V Leiden和凝血酶原G20210A突变的患病率
Clin Lab Haematol. 2006 Apr;28(2):111-6. doi: 10.1111/j.1365-2257.2006.00757.x.
8
Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature.一名17岁女孩，携带因子V莱顿杂合突变、凝血酶原G20210A突变、亚甲基四氢叶酸还原酶C677T突变，且纤溶酶原激活物抑制剂-1（PAI-1）突变纯合，出现与避孕相关的深静脉血栓形成和肺栓塞：一个具有多种遗传危险因素的家系报告及文献复习
Pathophysiol Haemost Thromb. 2010;37(1):24-9. doi: 10.1159/000319051. Epub 2010 Jul 20.
9
Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.携带因子 V 莱顿或凝血酶原 G20210A 突变的患者与无突变患者的静脉血栓栓塞类型和位置。
Clin Appl Thromb Hemost. 2010 Feb;16(1):66-70. doi: 10.1177/1076029608320721. Epub 2008 Sep 15.
10
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.凝血因子V莱顿突变与凝血酶原20210A联合作用对静脉血栓栓塞风险的影响——对8项病例对照研究的汇总分析，包括2310例病例和3204例对照。静脉血栓栓塞汇总分析研究组
Thromb Haemost. 2001 Sep;86(3):809-16.

引用本文的文献

1
Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK Biobank.在 FinnGen 和 UK Biobank 中，单一和双重杂合子携带因子 V Leiden 和凝血酶原 G20210A 的血栓形成风险。
Blood. 2024 Jun 6;143(23):2425-2432. doi: 10.1182/blood.2023023326.
2
Factor V Leiden G1691A and Prothrombin Gene G20210A Mutations on Pregnancy Outcome.凝血因子V莱顿G1691A突变和凝血酶原基因G20210A突变对妊娠结局的影响。
Cureus. 2021 Aug 15;13(8):e17185. doi: 10.7759/cureus.17185. eCollection 2021 Aug.
3
Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register.
血栓形成中心参与意大利 Start 2-Register 的真实临床环境中的血栓形成倾向检测。
Blood Transfus. 2021 May;19(3):244-252. doi: 10.2450/2021.0262-20. Epub 2021 Jan 27.
4
Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology.镰状细胞病：静脉血栓形成病理生理学的范例。
Int J Mol Sci. 2020 Jul 25;21(15):5279. doi: 10.3390/ijms21155279.
5
Gas embolism during endoscopic retrograde cholangiopancreatography: diagnosis and management.内镜逆行胰胆管造影术中的气体栓塞：诊断与处理
Ann Gastroenterol. 2019 Mar-Apr;32(2):156-167. doi: 10.20524/aog.2018.0339. Epub 2018 Dec 20.
6
Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility.凝血因子V Leiden基因G1691A多态性与股骨头坏死易感性的Meta分析。
Biomed Rep. 2013 Jul;1(4):594-598. doi: 10.3892/br.2013.93. Epub 2013 Apr 9.
7
Inherited risk factors for venous thromboembolism.遗传性静脉血栓栓塞症风险因素。
Nat Rev Cardiol. 2014 Mar;11(3):140-56. doi: 10.1038/nrcardio.2013.211. Epub 2014 Jan 14.
8
Necessity and risks of arterial blood sampling in healthy volunteer studies.健康志愿者研究中动脉采血的必要性和风险。
Clin Pharmacokinet. 2012 Oct 1;51(10):629-38. doi: 10.1007/s40262-012-0001-1.